Mrowietz U - Search Results

1

Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.

Bronckers IMGJ, Seyger MMB, West DP, Lara-Corrales I, Tollefson M, Tom WL, Hogeling M, Belazarian L, Zachariae C, Mahé E, Siegfried E, Philipp S, Szalai Z, Vleugels RA, Holland K, Murphy R, Baselga E, Cordoro K, Lambert J, Alexopoulos A, Mrowietz U, Kievit W, Paller AS; Psoriasis Investigator Group (PsIG) of the Pediatric Dermatology Research Alliance and the European Working Group on Pediatric Psoriasis (EWGPP). Bronckers IMGJ, et al. Among authors: mrowietz u. JAMA Dermatol. 2017 Nov 1;153(11):1147-1157. doi: 10.1001/jamadermatol.2017.3029. JAMA Dermatol. 2017. PMID: 28903160 Free PMC article.

2

Cyclosporine in psoriasis: a multicenter dose-finding study in severe plaque psoriasis. The German Multicenter Study.

Christophers E, Mrowietz U, Henneicke HH, Färber L, Welzel D. Christophers E, et al. Among authors: mrowietz u. J Am Acad Dermatol. 1992 Jan;26(1):86-90. doi: 10.1016/0190-9622(92)70012-5. J Am Acad Dermatol. 1992. PMID: 1732342 Clinical Trial.

3

Long-term maintenance therapy with cyclosporine and posttreatment survey in severe psoriasis: results of a multicenter study. German Multicenter Study.

Mrowietz U, Färber L, Henneicke-von Zepelin HH, Bachmann H, Welzel D, Christophers E. Mrowietz U, et al. J Am Acad Dermatol. 1995 Sep;33(3):470-5. doi: 10.1016/0190-9622(95)91393-9. J Am Acad Dermatol. 1995. PMID: 7657870 Clinical Trial.

4

Highly purified omega-3-polyunsaturated fatty acids for topical treatment of psoriasis. Results of a double-blind, placebo-controlled multicentre study.

Henneicke-von Zepelin HH, Mrowietz U, Färber L, Bruck-Borchers K, Schober C, Huber J, Lutz G, Kohnen R, Christophers E, Welzel D. Henneicke-von Zepelin HH, et al. Among authors: mrowietz u. Br J Dermatol. 1993 Dec;129(6):713-7. doi: 10.1111/j.1365-2133.1993.tb03338.x. Br J Dermatol. 1993. PMID: 8286257 Clinical Trial.

5

Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study.

Mrowietz U, Christophers E, Altmeyer P. Mrowietz U, et al. Br J Dermatol. 1998 Mar;138(3):456-60. doi: 10.1046/j.1365-2133.1998.02124.x. Br J Dermatol. 1998. PMID: 9580799 Clinical Trial.

6

Hyperpigmentation due to topical calcipotriol and photochemotherapy in two psoriatic patients.

Gläser R, Röwert J, Mrowietz U. Gläser R, et al. Among authors: mrowietz u. Br J Dermatol. 1998 Jul;139(1):148-51. doi: 10.1046/j.1365-2133.1998.02334.x. Br J Dermatol. 1998. PMID: 9764169

7

The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion.

Mrowietz U, Graeber M, Bräutigam M, Thurston M, Wagenaar A, Weidinger G, Christophers E. Mrowietz U, et al. Br J Dermatol. 1998 Dec;139(6):992-6. doi: 10.1046/j.1365-2133.1998.02554.x. Br J Dermatol. 1998. PMID: 9990361 Clinical Trial.

8

Lack of efficacy of topical mycophenolic acid in psoriasis vulgaris.

Geilen CC, Mrowietz U. Geilen CC, et al. Among authors: mrowietz u. J Am Acad Dermatol. 2000 May;42(5 Pt 1):837-40. doi: 10.1067/mjd.2000.105561. J Am Acad Dermatol. 2000. PMID: 10775867 Clinical Trial.

9

Advances in systemic therapy for psoriasis.

Mrowietz U. Mrowietz U. Clin Exp Dermatol. 2001 Jun;26(4):362-7. doi: 10.1046/j.1365-2230.2001.00835.x. Clin Exp Dermatol. 2001. PMID: 11422190 Review.

10

Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients.

Faerber L, Braeutigam M, Weidinger G, Mrowietz U, Christophers E, Schulze HJ, Mahrle G, Meffert H, Drechsler S. Faerber L, et al. Among authors: mrowietz u. Am J Clin Dermatol. 2001;2(1):41-7. doi: 10.2165/00128071-200102010-00007. Am J Clin Dermatol. 2001. PMID: 11702620

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

409 results

Search Page